Orion Biotech Opportunities Corp Price to Earnings Ratio (PE) Ratios, (ORIA) Valuation Ranking and Trends, Fundamental Ratios - CSIMarket
CSIMarket
 




Orion Biotech Opportunities Corp   (NASDAQ: ORIA)
    Sector • Financial    Industry • Blank Checks
   Industry • Blank Checks
   Sector • Financial
 





ORIA Price to Earnings Ratio Current (Sep 30 2022) (Jun 30 2022) (Mar 31 2022) (Dec 31 2021)
Diluted EPS 12 Trailing Months III. Quarter II. Quarter I. Quarter IV. Quarter
PE (TTM) Ratio current            28.07            58.44            44.83            44.83            44.83
Diluted EPS TTM Y / Y Change - % - % - % - % - %
Diluted EPS Y / Y Change - % -55.56 % - % - % - %
Stock performance to date 3.81 % 1.03 % 0.05 % -0.1 % -1.11 %

Price to earnings ratio Comment
Despite shareprice increase of 3.81 %, from beginning of IV. Quarter Orion Biotech Opportunities Corp 's current Price to earnings ratio has contracted due to eps growth of 0 %, to Pe of 28.07, from average Price to earnings ratio in III. Quarter of 58.44.

Within Financial sector 555 other companies have lower Price to earnings ratio.

What is Price to Earnings Ratio?
What is Orion Biotech Opportunities Corp Market Share?

Price to earnings ratio Company Ranking
Within: No.
Industry #0
Sector #556
S&P 500 #1769





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.